SMTL ID : 6r0q.4 (3 other biounits)

Mutant cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with thalidomide metabolite alpha-(o-carboxybenzamido)glutarimide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.24, C.27, C.90, C.93 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.24, A:C.27, A:C.90, A:C.93

1 x JNW: 2-[[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]carbamoyl]benzoic acid(Non-covalent)

JNW.2: 11 residues within 4Å: Chain A: N.50, P.51, H.52, H.56, F.77, S.78, W.79, W.85, H.96, W.99, Y.101 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:N.50, A:W.79, A:W.85, A:W.85, A:W.99 Hydrogen bonds: A:N.50, A:F.77, A:W.79 Salt bridges: A:H.56, A:H.96

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heim, C. et al., De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives. J.Med.Chem. (2019)

Release Date

2019-08-07

Peptides

Cereblon isoform 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Cereblon isoform 4

Related Entries With Identical Sequence